UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 61,824 Shares of Perrigo Company plc (NYSE:PRGO)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Perrigo Company plc (NYSE:PRGO - Free Report) by 14.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 480,961 shares of the company's stock after buying an additional 61,824 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.35% of Perrigo worth $12,366,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. iSAM Funds UK Ltd purchased a new position in shares of Perrigo in the fourth quarter worth $242,000. Vestal Point Capital LP purchased a new position in Perrigo in the 4th quarter valued at $9,641,000. Two Sigma Advisers LP lifted its stake in Perrigo by 3.5% in the 4th quarter. Two Sigma Advisers LP now owns 131,500 shares of the company's stock worth $3,381,000 after purchasing an additional 4,500 shares in the last quarter. Two Sigma Investments LP lifted its position in Perrigo by 17.9% during the fourth quarter. Two Sigma Investments LP now owns 112,581 shares of the company's stock worth $2,894,000 after buying an additional 17,106 shares in the last quarter. Finally, State of Wyoming raised its position in shares of Perrigo by 21.9% during the 4th quarter. State of Wyoming now owns 8,002 shares of the company's stock valued at $206,000 after buying an additional 1,440 shares during the period. Institutional investors own 95.91% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of Perrigo from a "hold" rating to a "buy" rating in a report on Saturday, May 24th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Perrigo has an average rating of "Hold" and a consensus price target of $33.00.

Perrigo Price Performance

NYSE:PRGO traded down $0.32 during trading hours on Friday, reaching $26.81. 1,041,776 shares of the company traded hands, compared to its average volume of 1,508,477. The firm's 50-day moving average is $26.10 and its 200-day moving average is $26.20. Perrigo Company plc has a 1-year low of $23.14 and a 1-year high of $30.93. The stock has a market cap of $3.69 billion, a P/E ratio of -22.91 and a beta of 0.45. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77.

Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.04. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The company had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the previous year, the firm earned $0.29 earnings per share. Perrigo's revenue for the quarter was down 3.5% on a year-over-year basis. Equities research analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Friday, May 30th will be paid a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.33%. The ex-dividend date is Friday, May 30th. Perrigo's dividend payout ratio is currently -88.55%.

Insider Transactions at Perrigo

In other news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the transaction, the executive vice president now owns 33,666 shares in the company, valued at $923,795.04. This represents a 18.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.70% of the company's stock.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.